Henry Schein, Inc.(HSIC)

Henry Schein, Inc. provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, personal protective equipment, and high-tech and digital restoration equipment, as well as equipment repair services. This segment also provides medical products comprising branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins. The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners. This segment also provides value-added practice solutions, which comprise financial services on a non-recourse basis, e-services, practice technology, network, and hardware services, as well as continuing education services for practitioners, and consulting and other services. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.
Latest News & Analysis
Henry Schein Q3 Beats as KKR Doubles Down on Cloud Transformation
Third-quarter results prove AWS partnership is non-disruptive as KKR expands ownership to 19.9%, signaling $200M operating income opportunity.
Henry Schein One and AWS Collaborate to Transform Global Dentistry with Generative AI
Henry Schein's AWS partnership marks a strategic pivot toward higher-margin software and clinical intelligence services.
Henry Schein (HSIC) Q4 2024 Earnings: Analyst Expectations
A comprehensive intraday update on Henry Schein (HSIC), focusing on Q4 2024 earnings preview, strategic investments, and market trends.